NO910080L - Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat. - Google Patents

Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat.

Info

Publication number
NO910080L
NO910080L NO91910080A NO910080A NO910080L NO 910080 L NO910080 L NO 910080L NO 91910080 A NO91910080 A NO 91910080A NO 910080 A NO910080 A NO 910080A NO 910080 L NO910080 L NO 910080L
Authority
NO
Norway
Prior art keywords
dosage units
vismut
subsitrate
units including
including colloidal
Prior art date
Application number
NO91910080A
Other languages
English (en)
Other versions
NO910080D0 (no
Inventor
Jan Willem Groenendaal
Aart Muhlenbruch
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NO910080D0 publication Critical patent/NO910080D0/no
Publication of NO910080L publication Critical patent/NO910080L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91910080A 1990-01-09 1991-01-08 Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat. NO910080L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200064 1990-01-09

Publications (2)

Publication Number Publication Date
NO910080D0 NO910080D0 (no) 1991-01-08
NO910080L true NO910080L (no) 1991-07-10

Family

ID=8204917

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910080A NO910080L (no) 1990-01-09 1991-01-08 Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat.

Country Status (18)

Country Link
US (1) US5264222A (no)
EP (1) EP0437294B1 (no)
KR (1) KR910014124A (no)
AT (1) ATE101039T1 (no)
AU (1) AU638083B2 (no)
CA (1) CA2033870A1 (no)
DE (1) DE69101111T2 (no)
DK (1) DK0437294T3 (no)
ES (1) ES2063432T3 (no)
FI (1) FI910088A (no)
HU (1) HU204707B (no)
IE (1) IE910057A1 (no)
IL (1) IL96904A0 (no)
MY (1) MY106371A (no)
NO (1) NO910080L (no)
NZ (1) NZ236721A (no)
PT (1) PT96437A (no)
ZA (1) ZA91178B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
WO1996024342A1 (en) * 1995-02-07 1996-08-15 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
WO1997007757A1 (en) * 1995-08-24 1997-03-06 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
HUP9904073A3 (en) * 1996-11-22 2000-04-28 Procter & Gamble Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
US20210106648A1 (en) * 2019-10-11 2021-04-15 TOBEBIO Novel Drug Laboratory Co., Ltd. Synergistic combination of chemotherapy and peptide for treating cancer
CN111214443A (zh) * 2020-02-23 2020-06-02 北京鑫开元医药科技有限公司 一种枸橼酸铋钾颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4670245A (en) * 1984-04-27 1987-06-02 Vasquez Tony E Diagnostic procedures using radiolabeled colloidal bismuth subcitrate and related compounds
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
GB8612401D0 (en) * 1986-05-21 1986-06-25 Evode Ltd Liquid polmers
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines

Also Published As

Publication number Publication date
ATE101039T1 (de) 1994-02-15
MY106371A (en) 1995-05-30
CA2033870A1 (en) 1991-07-10
ZA91178B (en) 1991-10-30
US5264222A (en) 1993-11-23
AU6869391A (en) 1991-07-11
FI910088A (fi) 1991-07-10
AU638083B2 (en) 1993-06-17
NZ236721A (en) 1992-08-26
IE910057A1 (en) 1991-07-17
NO910080D0 (no) 1991-01-08
KR910014124A (ko) 1991-08-31
DK0437294T3 (da) 1994-03-07
EP0437294B1 (en) 1994-02-02
EP0437294A1 (en) 1991-07-17
ES2063432T3 (es) 1995-01-01
DE69101111D1 (de) 1994-03-17
PT96437A (pt) 1991-10-15
HU204707B (en) 1992-02-28
DE69101111T2 (de) 1994-07-28
IL96904A0 (en) 1992-03-29
FI910088A0 (fi) 1991-01-07

Similar Documents

Publication Publication Date Title
BR1100776A (pt) Forma de dosagem farmacêutica comprimida e obréia farmacêutica comprimida.
NO910080L (no) Svelgbare doseringsenheter omfattende kolloidalt vismut-subsitrat.
IE862554L (en) Pharmaceutical compositions
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
GB9016789D0 (en) Medicament administering devices
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
MX9200532A (es) Agente farmaceuticos.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
SG181694G (en) Solid oral administration forms containing ifosfamide as active agent
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
IL66673A (en) 3'-substituted-5'-(2-amino-4-pyridyl)-1',2',4'-triazoles,their preparation and pharmaceutical compositions comprising them
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2682108B1 (fr) Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
FR2667066B2 (fr) N-heterocyclyl glycinamides, leur preparation et les medicaments les contenant.